BTIG Reiterates Neutral Rating on Insight Molecular Diagnostics Inc. (IMDX)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall St eyes best day in a month as Anthropic's IPO filing propels AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
| (NASDAQ: IMDX) | Delayed: 2.96 +0.13 (4.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.83 | 52 Week High | $ | |||
| Open | $2.89 | 52 Week Low | $ | |||
| Day High | $2.99 | P/E | N/A | |||
| Day Low | $2.77 | EPS | $ | |||
| Volume | 71,207 | |||||
